Bifidobacterium animalis subsp. lactis BL-99 ameliorates age-related intestinal hypomotility in older adults: a randomized controlled trial
A microbiota-BA-SMC signaling axis that ameliorates age-related intestinal hypomotility is established and positioning both BL-99 and TCDCA as precision therapeutic candidates targeting SMC-related dysmotility is positioned.